AstraZeneca completes Phase 1 laroprovstat/ezetimibe bioavailability study in healthy adultsSep 28Weekly roundup, 2 itemsacalabrutinibAstraZeneca
Novartis roundup: ITP real-world data completed; three trials registered; Utah study terminatedSep 4Weekly roundup, 6 itemsDDY391inclisiran
Silence Therapeutics reports Q2 2026 results and divesiran trial progressAug 10Quarterly updateSilence Therapeutics plc
NewAmsterdam reports positive CHMP opinion for obicetrapib, sets PREVAIL and RUBENS timelinesAug 5Quarterly updateNewAmsterdam Pharma Co N.V.
NewAmsterdam and Menarini get positive EU CHMP opinion for obicetrapib medicinesJul 24Regulatory milestoneNewAmsterdam Pharma Co N.V.
Sign inSign in